China Sxt Pharmaceuticals Stock Filter Stocks by Fundamentals
| SXTC Stock | USD 1.02 0.03 3.03% |
China SXT Pharmaceuticals fundamentals help investors to digest information that contributes to China SXT's financial success or failures. It also enables traders to predict the movement of China Stock. The fundamental analysis module provides a way to measure China SXT's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to China SXT stock.
China | Shares Owned by Insiders |
China SXT Institutional Holders
Institutional Holdings refers to the ownership stake in China SXT that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of China SXT's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing China SXT's value.| Shares | Ubs Group Ag | 2023-12-31 | 6.4 K | Acadian Asset Management Llc | 2023-12-31 | 2.8 K | Qube Research & Technologies | 2023-12-31 | 3.0 | Renaissance Technologies Corp | 2023-09-30 | 0.0 | Cetera Advisor Networks Llc | 2023-09-30 | 0.0 |
China Fundamentals
| Return On Equity | -1.42 | ||||
| Return On Asset | -0.46 | ||||
| Operating Margin | (9.95) % | ||||
| Current Valuation | (7.17 M) | ||||
| Shares Outstanding | 565.53 K | ||||
| Shares Owned By Insiders | 22.00 % | ||||
| Shares Owned By Institutions | 1.62 % | ||||
| Number Of Shares Shorted | 26.24 K | ||||
| Price To Earning | 5.73 X | ||||
| Price To Book | 0.05 X | ||||
| Price To Sales | 0.46 X | ||||
| Revenue | 1.97 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (5.36 M) | ||||
| Net Income | (5.93 M) | ||||
| Cash And Equivalents | 15.52 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 3.76 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 6.97 X | ||||
| Cash Flow From Operations | (80.76 K) | ||||
| Short Ratio | 0.14 X | ||||
| Earnings Per Share | (26.95) X | ||||
| Number Of Employees | 78 | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 559.88 K | ||||
| Total Asset | 29.55 M | ||||
| Retained Earnings | (21.61 M) | ||||
| Working Capital | 5.02 M | ||||
| Net Asset | 29.55 M |
About China SXT Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China SXT Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China SXT using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China SXT Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China SXT in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China SXT's short interest history, or implied volatility extrapolated from China SXT options trading.
Currently Active Assets on Macroaxis
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:Check out China SXT Piotroski F Score and China SXT Altman Z Score analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for China Stock analysis
When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is China SXT's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.426 | Earnings Share (26.95) | Revenue Per Share 3.65 | Quarterly Revenue Growth (0.22) | Return On Assets (0.46) |
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.